Logo image of RBX.CA

ROBEX RESOURCES INC (RBX.CA) Stock Fundamental Analysis

TSX-V:RBX - CA76125Y6001 - Common Stock

3.34 CAD
+0.08 (+2.45%)
Last: 8/29/2025, 7:00:00 PM
Fundamental Rating

4

RBX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 803 industry peers in the Metals & Mining industry. While RBX is still in line with the averages on profitability rating, there are concerns on its financial health. RBX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

RBX had negative earnings in the past year.
RBX had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RBX reported negative net income in multiple years.
RBX had a positive operating cash flow in each of the past 5 years.
RBX.CA Yearly Net Income VS EBIT VS OCF VS FCFRBX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

The Return On Assets of RBX (-8.65%) is better than 62.89% of its industry peers.
With a decent Return On Equity value of -14.07%, RBX is doing good in the industry, outperforming 60.52% of the companies in the same industry.
RBX has a better Return On Invested Capital (9.17%) than 93.65% of its industry peers.
RBX had an Average Return On Invested Capital over the past 3 years of 12.03%. This is in line with the industry average of 11.82%.
Industry RankSector Rank
ROA -8.65%
ROE -14.07%
ROIC 9.17%
ROA(3y)2.28%
ROA(5y)11.24%
ROE(3y)2.59%
ROE(5y)14.71%
ROIC(3y)12.03%
ROIC(5y)19.03%
RBX.CA Yearly ROA, ROE, ROICRBX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

RBX's Operating Margin of 27.61% is amongst the best of the industry. RBX outperforms 93.65% of its industry peers.
In the last couple of years the Operating Margin of RBX has grown nicely.
Looking at the Gross Margin, with a value of 90.42%, RBX belongs to the top of the industry, outperforming 99.75% of the companies in the same industry.
Industry RankSector Rank
OM 27.61%
PM (TTM) N/A
GM 90.42%
OM growth 3Y-8.9%
OM growth 5Y3.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RBX.CA Yearly Profit, Operating, Gross MarginsRBX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so RBX is still creating some value.
RBX has more shares outstanding than it did 1 year ago.
RBX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, RBX has an improved debt to assets ratio.
RBX.CA Yearly Shares OutstandingRBX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
RBX.CA Yearly Total Debt VS Total AssetsRBX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.62 indicates that RBX is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.62, RBX is in line with its industry, outperforming 54.79% of the companies in the same industry.
RBX has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.05, RBX is not doing good in the industry: 60.40% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 2.62
ROIC/WACC0.96
WACC9.58%
RBX.CA Yearly LT Debt VS Equity VS FCFRBX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

RBX has a Current Ratio of 0.69. This is a bad value and indicates that RBX is not financially healthy enough and could expect problems in meeting its short term obligations.
RBX has a Current ratio of 0.69. This is in the lower half of the industry: RBX underperforms 65.26% of its industry peers.
A Quick Ratio of 0.56 indicates that RBX may have some problems paying its short term obligations.
With a Quick ratio value of 0.56, RBX is not doing good in the industry: 66.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.56
RBX.CA Yearly Current Assets VS Current LiabilitesRBX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 67.07% over the past year.
Looking at the last year, RBX shows a decrease in Revenue. The Revenue has decreased by -0.35% in the last year.
Measured over the past years, RBX shows a quite strong growth in Revenue. The Revenue has been growing by 9.81% on average per year.
EPS 1Y (TTM)67.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.64%
Revenue 1Y (TTM)-0.35%
Revenue growth 3Y15.09%
Revenue growth 5Y9.81%
Sales Q2Q%-23.44%

3.2 Future

RBX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.99% yearly.
The Revenue is expected to grow by 77.69% on average over the next years. This is a very strong growth
EPS Next Y-106.87%
EPS Next 2Y59.9%
EPS Next 3Y53.99%
EPS Next 5YN/A
Revenue Next Year-18.59%
Revenue Next 2Y125.72%
Revenue Next 3Y77.69%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RBX.CA Yearly Revenue VS EstimatesRBX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
RBX.CA Yearly EPS VS EstimatesRBX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.2 0.4 0.6

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RBX. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 6.16, the valuation of RBX can be described as very cheap.
RBX's Price/Forward Earnings ratio is rather cheap when compared to the industry. RBX is cheaper than 95.89% of the companies in the same industry.
RBX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.16
RBX.CA Price Earnings VS Forward Price EarningsRBX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

94.02% of the companies in the same industry are more expensive than RBX, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.97
RBX.CA Per share dataRBX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

RBX's earnings are expected to grow with 53.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.9%
EPS Next 3Y53.99%

0

5. Dividend

5.1 Amount

RBX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ROBEX RESOURCES INC

TSX-V:RBX (8/29/2025, 7:00:00 PM)

3.34

+0.08 (+2.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-31 2025-07-31
Earnings (Next)12-01 2025-12-01
Inst Owners28.95%
Inst Owner ChangeN/A
Ins Owners2.73%
Ins Owner ChangeN/A
Market Cap730.46M
Analysts84
Price Target5.32 (59.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-3.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)18.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-119.13%
EPS NY rev (3m)-119.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.8%
Revenue NY rev (3m)14.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.16
P/S 3.86
P/FCF N/A
P/OCF N/A
P/B 2.15
P/tB 2.15
EV/EBITDA 7.97
EPS(TTM)-0.25
EYN/A
EPS(NY)0.54
Fwd EY16.24%
FCF(TTM)-0.77
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.87
BVpS1.55
TBVpS1.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.65%
ROE -14.07%
ROCE 12.74%
ROIC 9.17%
ROICexc 9.68%
ROICexgc 9.69%
OM 27.61%
PM (TTM) N/A
GM 90.42%
FCFM N/A
ROA(3y)2.28%
ROA(5y)11.24%
ROE(3y)2.59%
ROE(5y)14.71%
ROIC(3y)12.03%
ROIC(5y)19.03%
ROICexc(3y)12.9%
ROICexc(5y)21.3%
ROICexgc(3y)12.93%
ROICexgc(5y)21.33%
ROCE(3y)19.03%
ROCE(5y)28.34%
ROICexcg growth 3Y-24.44%
ROICexcg growth 5Y-12.48%
ROICexc growth 3Y-24.47%
ROICexc growth 5Y-12.5%
OM growth 3Y-8.9%
OM growth 5Y3.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 0.2
Cap/Depr 423.29%
Cap/Sales 87.76%
Interest Coverage 12.98
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.56
Altman-Z 2.62
F-Score2
WACC9.58%
ROIC/WACC0.96
Cap/Depr(3y)263.2%
Cap/Depr(5y)246.88%
Cap/Sales(3y)42.52%
Cap/Sales(5y)37.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.64%
EPS Next Y-106.87%
EPS Next 2Y59.9%
EPS Next 3Y53.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.35%
Revenue growth 3Y15.09%
Revenue growth 5Y9.81%
Sales Q2Q%-23.44%
Revenue Next Year-18.59%
Revenue Next 2Y125.72%
Revenue Next 3Y77.69%
Revenue Next 5YN/A
EBIT growth 1Y-13.03%
EBIT growth 3Y4.85%
EBIT growth 5Y13.61%
EBIT Next Year34.47%
EBIT Next 3Y117.39%
EBIT Next 5YN/A
FCF growth 1Y-6229.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-103.43%
OCF growth 3Y2.21%
OCF growth 5Y0.45%